Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Johnson & Johnson withdraws from norastemizole collaboration

May 18, 1999

SmithKline Beecham describes new series of CCR5 receptor modulators

May 17, 1999

PathoGenesis launches TOBI in second market

May 13, 1999

Asahi Glass describes dual NK1/NK2 antagonists

May 12, 1999

Antiallergic/antiinflammatory agents in the Nikken Chemicals pipeline

May 11, 1999

New peptide tachykinin antagonists from Asahi Glass

May 11, 1999

Flixotide submitted for COPD in major markets

May 10, 1999

NA-00226B and C, produced by Streptomyces, inhibit cAMP PDE activity

May 10, 1999

Chugai and Dainippon Ink & Chemicals to codevelop new antiallergic agent

May 6, 1999

Alpha1-antitrypsin may be a future treatment for asthma

May 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...